Fangming Yang

机构：BGI Group (China), BGI Genomics

发表论文 8 篇 · 总被引 257 次 · h-index 7

代表论文

• Divergent age-associated and metabolism-associated gut microbiome signatures modulate cardiovascular disease risk (2024 · Nature Medicine · 被引 68)
• The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-κB/NLRP3 signaling (2020 · Acta Pharmacologica Sinica · 被引 65)
• Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis (2022 · Frontiers in Pharmacology · 被引 40)
• A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis (2021 · Acta Pharmacologica Sinica · 被引 32)
• Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes (2024 · Med · 被引 27)
• Tissue-resident microbiota impacts colorectal cancer progression and prognosis (2025 · Nature Communications · 被引 14)